Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
sar-100842 | lysophosphatidic acid receptor 1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Systemic Scleroderma[MeSHID:D012595] Fibrosis[MeSHID:D005355] |
NA | phase 2 | unknown |
sar-100842 | lysophosphatidate-3 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Systemic Scleroderma[MeSHID:D012595] Fibrosis[MeSHID:D005355] |
NA | phase 2 | unknown |
click here to return to the previous page |